Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.03
(0.0%)
CNY 8.03
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 671.62 Million CNY | 2.54% |
| 2022 | 654.97 Million CNY | -5.62% |
| 2021 | 693.96 Million CNY | -8.46% |
| 2020 | 758.13 Million CNY | 11.29% |
| 2019 | 681.22 Million CNY | 24.82% |
| 2018 | 545.76 Million CNY | 60.1% |
| 2017 | 340.89 Million CNY | 6.12% |
| 2016 | 321.22 Million CNY | 1.35% |
| 2015 | 316.95 Million CNY | -1.02% |
| 2014 | 320.23 Million CNY | 20.36% |
| 2013 | 266.05 Million CNY | 4.16% |
| 2012 | 255.43 Million CNY | 18.65% |
| 2011 | 215.28 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 160.66 Million CNY | -17.17% |
| 2024 Q1 | 153.05 Million CNY | -27.85% |
| 2024 Q2 | 198.91 Million CNY | 29.96% |
| 2023 Q3 | 138.62 Million CNY | -19.88% |
| 2023 Q4 | 212.13 Million CNY | 53.03% |
| 2023 FY | 671.62 Million CNY | 2.54% |
| 2023 Q1 | 147.83 Million CNY | -17.3% |
| 2023 Q2 | 173.02 Million CNY | 17.05% |
| 2022 FY | 654.97 Million CNY | -5.62% |
| 2022 Q3 | 158.06 Million CNY | -0.28% |
| 2022 Q4 | 178.75 Million CNY | 13.09% |
| 2022 Q2 | 158.5 Million CNY | -0.71% |
| 2022 Q1 | 159.64 Million CNY | -6.22% |
| 2021 Q2 | 186.66 Million CNY | 9.03% |
| 2021 Q1 | 171.2 Million CNY | -30.35% |
| 2021 Q3 | 165.86 Million CNY | -11.14% |
| 2021 Q4 | 170.23 Million CNY | 2.63% |
| 2021 FY | 693.96 Million CNY | -8.46% |
| 2020 Q1 | 151.82 Million CNY | -16.6% |
| 2020 FY | 758.13 Million CNY | 11.29% |
| 2020 Q3 | 182.21 Million CNY | 2.2% |
| 2020 Q4 | 245.79 Million CNY | 34.9% |
| 2020 Q2 | 178.29 Million CNY | 17.44% |
| 2019 Q1 | 146.18 Million CNY | 0.03% |
| 2019 FY | 681.22 Million CNY | 24.82% |
| 2019 Q4 | 182.03 Million CNY | 13.6% |
| 2019 Q3 | 160.24 Million CNY | -16.87% |
| 2019 Q2 | 192.76 Million CNY | 31.86% |
| 2018 Q1 | 123.03 Million CNY | 7.81% |
| 2018 Q2 | 128.48 Million CNY | 4.43% |
| 2018 Q4 | 146.14 Million CNY | -1.32% |
| 2018 Q3 | 148.1 Million CNY | 15.27% |
| 2018 FY | 545.76 Million CNY | 60.1% |
| 2017 Q4 | 114.11 Million CNY | 45.98% |
| 2017 Q1 | 82.31 Million CNY | -23.77% |
| 2017 Q2 | 66.29 Million CNY | -19.46% |
| 2017 Q3 | 78.17 Million CNY | 17.91% |
| 2017 FY | 340.89 Million CNY | 6.12% |
| 2016 Q2 | 81.48 Million CNY | 15.31% |
| 2016 Q4 | 107.97 Million CNY | 76.74% |
| 2016 Q3 | 61.09 Million CNY | -25.02% |
| 2016 Q1 | 70.66 Million CNY | 0.0% |
| 2016 FY | 321.22 Million CNY | 1.35% |
| 2015 FY | 316.95 Million CNY | -1.02% |
| 2014 Q2 | 72.61 Million CNY | 0.0% |
| 2014 FY | 320.23 Million CNY | 20.36% |
| 2014 Q1 | 72.61 Million CNY | 0.0% |
| 2013 FY | 266.05 Million CNY | 4.16% |
| 2012 FY | 255.43 Million CNY | 18.65% |
| 2011 FY | 215.28 Million CNY | 0.0% |